Proposed rule to streamline, save money

A new proposed rule calls for reforms to Medicare regulations identified as unnecessary, obsolete or excessively burdensome on hospitals and healthcare providers that would save nearly $676 million annually, and $3.4 billion over five years. The Centers for Medicare & Medicaid Services' (CMS) proposed rule supports President Barack Obama’s call on federal agencies to modify and streamline regulations on business.

The proposed rule is designed to help providers operate more efficiently by getting rid of regulations that are out of date or no longer needed. Many of the rule’s provisions streamline the standards providers must meet to participate in the Medicare and Medicaid programs without jeopardizing beneficiary safety.

For example, a key provision reduces the burden on very small critical access hospitals, as well as rural health clinics and federally qualified health centers, by eliminating the requirement that a physician be held to an excessively prescriptive schedule for being onsite once every two weeks. This provision seeks to address the geographic barriers and remoteness of many rural facilities, and recognize telemedicine improvements and expansions that allow physicians to provide many types of care at lower costs, while maintaining high-quality care.

Among other provisions, the proposed rule would:

  • Save hospitals significant resources by permitting registered dietitians to order patient diets independently, which they are trained to do, without requiring the supervision or approval of a physician or other practitioner. This frees up time for physicians and other practitioners to care for patients.
  • Eliminate unnecessary requirements that ambulatory surgical centers must meet in order to provide radiological services that are an integral part of their surgical procedures, permitting them greater flexibility for physician supervision requirements.                                                   
  • Permit trained nuclear medicine technicians in hospitals to prepare radiopharmaceuticals for nuclear medicine without the supervising physician or pharmacist constantly being present, which helps speed services to patients, particularly during off hours.
  • Eliminate a redundant data submission requirement and an unnecessary survey process for transplant centers while maintaining strong federal oversight.


View the new proposed rule.


 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.